105 related articles for article (PubMed ID: 36513631)
1. BET protein inhibition sensitizes glioblastoma cells to temozolomide treatment by attenuating MGMT expression.
Tancredi A; Gusyatiner O; Bady P; Buri MC; Lomazzi R; Chiesi D; Messerer M; Hegi ME
Cell Death Dis; 2022 Dec; 13(12):1037. PubMed ID: 36513631
[TBL] [Abstract][Full Text] [Related]
2. Delineation of MGMT Hypermethylation as a Biomarker for Veliparib-Mediated Temozolomide-Sensitizing Therapy of Glioblastoma.
Gupta SK; Kizilbash SH; Carlson BL; Mladek AC; Boakye-Agyeman F; Bakken KK; Pokorny JL; Schroeder MA; Decker PA; Cen L; Eckel-Passow JE; Sarkar G; Ballman KV; Reid JM; Jenkins RB; Verhaak RG; Sulman EP; Kitange GJ; Sarkaria JN
J Natl Cancer Inst; 2016 May; 108(5):. PubMed ID: 26615020
[TBL] [Abstract][Full Text] [Related]
3. EPIC-0628 abrogates HOTAIR/EZH2 interaction and enhances the temozolomide efficacy via promoting ATF3 expression and inhibiting DNA damage repair in glioblastoma.
Yang E; Hong B; Wang Y; Wang Q; Zhao J; Cui X; Wu Y; Yang S; Su D; Liu X; Kang C
Cancer Lett; 2024 Apr; 588():216812. PubMed ID: 38490327
[TBL] [Abstract][Full Text] [Related]
4. USP19 regulates DNA methylation damage repair and confers temozolomide resistance through MGMT stabilization.
Liu J; Wang K; Zhu Q; Zhang Y; Chen Y; Lou Z; Yuan J
CNS Neurosci Ther; 2024 Apr; 30(4):e14711. PubMed ID: 38644551
[TBL] [Abstract][Full Text] [Related]
5. Glioblastoma with high O6-methyl-guanine DNA methyltransferase expression are more immunologically active than tumors with low
Kushihara Y; Tanaka S; Kobayashi Y; Nagaoka K; Kikuchi M; Nejo T; Yamazawa E; Nambu S; Kugasawa K; Takami H; Takayanagi S; Saito N; Kakimi K
Front Immunol; 2024; 15():1328375. PubMed ID: 38288307
[TBL] [Abstract][Full Text] [Related]
6. PARP1-MGMT complex underpins pathway crosstalk in O
Cropper JD; Alimbetov DS; Brown KTG; Likhotvorik RI; Robles AJ; Guerra JT; He B; Chen Y; Kwon Y; Kurmasheva RT
J Hematol Oncol; 2022 Oct; 15(1):146. PubMed ID: 36242092
[TBL] [Abstract][Full Text] [Related]
7. Differential gene expression-based connectivity mapping identified novel drug candidate and improved Temozolomide efficacy for Glioblastoma.
Vengoji R; Atri P; Macha MA; Seshacharyulu P; Perumal N; Mallya K; Liu Y; Smith LM; Rachagani S; Mahapatra S; Ponnusamy MP; Jain M; Batra SK; Shonka N
J Exp Clin Cancer Res; 2021 Oct; 40(1):335. PubMed ID: 34696786
[TBL] [Abstract][Full Text] [Related]
8. MGMT inhibition regulates radioresponse in GBM, GSC, and melanoma.
Yun HS; Kramp TR; Palanichamy K; Tofilon PJ; Camphausen K
Sci Rep; 2024 May; 14(1):12363. PubMed ID: 38811596
[TBL] [Abstract][Full Text] [Related]
9. A genome-wide association analysis of temozolomide response using lymphoblastoid cell lines shows a clinically relevant association with MGMT.
Brown CC; Havener TM; Medina MW; Auman JT; Mangravite LM; Krauss RM; McLeod HL; Motsinger-Reif AA
Pharmacogenet Genomics; 2012 Nov; 22(11):796-802. PubMed ID: 23047291
[TBL] [Abstract][Full Text] [Related]
10. Temozolomide is additive with cytotoxic effect of irradiation in canine glioma cell lines.
Tresch NS; Fuchs D; Morandi L; Tonon C; Rohrer Bley C; Nytko KJ
Vet Med Sci; 2021 Nov; 7(6):2124-2134. PubMed ID: 34477324
[TBL] [Abstract][Full Text] [Related]
11. Proteomic and metabolomic analyses illustrate the mechanisms of expression of the O
Chen X; Sun J; Li Y; Jiang W; Li Z; Mao J; Zhou L; Chen S; Tan G
CNS Neurosci Ther; 2024 Feb; 30(2):e14415. PubMed ID: 37641495
[TBL] [Abstract][Full Text] [Related]
12. Identification of TMZ resistance-associated histone post-translational modifications in glioblastoma using multi-omics data.
Ye L; Gu L; Wang Y; Xing H; Li P; Guo X; Wang Y; Ma W
CNS Neurosci Ther; 2024 Mar; 30(3):e14649. PubMed ID: 38448295
[TBL] [Abstract][Full Text] [Related]
13. Adoptive cell therapy for high grade gliomas using simultaneous temozolomide and intracranial mgmt-modified γδ t cells following standard post-resection chemotherapy and radiotherapy: current strategy and future directions.
Nabors LB; Lamb LS; Goswami T; Rochlin K; Youngblood SL
Front Immunol; 2024; 15():1299044. PubMed ID: 38384458
[TBL] [Abstract][Full Text] [Related]
14. MSH6 mutations arise in glioblastomas during temozolomide therapy and mediate temozolomide resistance.
Yip S; Miao J; Cahill DP; Iafrate AJ; Aldape K; Nutt CL; Louis DN
Clin Cancer Res; 2009 Jul; 15(14):4622-9. PubMed ID: 19584161
[TBL] [Abstract][Full Text] [Related]
15. mTOR target NDRG1 confers MGMT-dependent resistance to alkylating chemotherapy.
Weiler M; Blaes J; Pusch S; Sahm F; Czabanka M; Luger S; Bunse L; Solecki G; Eichwald V; Jugold M; Hodecker S; Osswald M; Meisner C; Hielscher T; Rübmann P; Pfenning PN; Ronellenfitsch M; Kempf T; Schnölzer M; Abdollahi A; Lang F; Bendszus M; von Deimling A; Winkler F; Weller M; Vajkoczy P; Platten M; Wick W
Proc Natl Acad Sci U S A; 2014 Jan; 111(1):409-14. PubMed ID: 24367102
[TBL] [Abstract][Full Text] [Related]
16. Trps1 is associated with the multidrug resistance of lung cancer cell by regulating MGMT gene expression.
Liu H; Liao Y; Tang M; Wu T; Tan D; Zhang S; Wang H
Cancer Med; 2018 May; 7(5):1921-1932. PubMed ID: 29601666
[TBL] [Abstract][Full Text] [Related]
17. Epigenetic downregulation of O
Wang Z; Liu Z; Wang PS; Lin HP; Rea M; Kondo K; Yang C
Environ Pollut; 2024 Jan; 341():122978. PubMed ID: 37995958
[TBL] [Abstract][Full Text] [Related]
18. A chloromethyl-triazole fluorescent chemosensor for O
Ayan S; Rotaru AM; Kaye EG; Juneau G; Das S; Wilds CJ; Beharry AA
Org Biomol Chem; 2024 Apr; 22(14):2749-2753. PubMed ID: 38502038
[TBL] [Abstract][Full Text] [Related]
19. The impact of survivorship bias in glioblastoma research.
Pasqualetti F; Barberis A; Zanotti S; Montemurro N; De Salvo GL; Soffietti R; Mazzanti CM; Ius T; Caffo M; Paiar F; Bocci G; Lombardi G; Harris AL; Buffa FM
Crit Rev Oncol Hematol; 2023 Aug; 188():104065. PubMed ID: 37392899
[TBL] [Abstract][Full Text] [Related]
20. Selective regulation of chemosensitivity in glioblastoma by phosphatidylinositol 3-kinase beta.
Pridham KJ; Hutchings KR; Beck P; Liu M; Xu E; Saechin E; Bui V; Patel C; Solis J; Huang L; Tegge A; Kelly DF; Sheng Z
iScience; 2024 Jun; 27(6):109921. PubMed ID: 38812542
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
